| abstract |
a) 0,01-0,4 Gew.-% Nimodipin, bezogen auf 100 Gewichtsteile eines Lösungsmittels bestehend aus b) 30-70 Gew.-% Wassern 15-40 Gew.-% Propylenglykol und/oder Polyethylenglykol 15-30 Gew.-% Ethanol sowie gegebenenfalls übliche Hilfs- und/oder Zuschlagstoffe;Containing parenteral formulation a) 0.01-0.4 wt .-% nimodipine, based on 100 parts by weight of a solvent consisting of b) 30-70% by weight water 15-40% by weight propylene glycol and / or polyethylene glycol 15-30% by weight ethanol and, if appropriate, customary auxiliaries and / or additives;n n n their use in combating diseases and a process for their preparation by dissolving nimodipine first in ethanol, propylene glycol and / or polyethylene glycol and then adding water. |